Medicare Enrolled
Dr. Michael Borofsky, M.D.
Optician · Wyomissing, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Borofsky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Borofsky?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Borofsky
Dr. Michael Borofsky is an optician specialist in Wyomissing, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Borofsky performed 234,016 Medicare services across 4,615 unique beneficiaries.
Between the years covered by Open Payments, Dr. Borofsky received a total of $9,588 from 36 pharmaceutical and/or device companies across 576 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Borofsky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 0% volume in PA
$9,588 industry payments
Medicare Practice Summary
Medicare Utilization ↗234,016
Medicare services
Top 0% in PA for optician
4,615
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11,144 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 115,026 | $5 | $8 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
66,840 | $4 | $14 |
| Denosumab injection (Prolia/Xgeva) | 19,680 | $18 | $30 |
| Romosozumab injection (Evenity) for osteoporosis | 8,820 | $8 | $15 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
5,900 | $11 | $42 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
5,400 | $34 | $83 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
3,770 | $26 | $100 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,768 | $1 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
583 | $89 | $140 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
581 | $11 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
452 | $67 | $110 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
434 | $17 | $46 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
350 | $0 | $15 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
287 | $91 | $290 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
231 | $8 | $10 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
182 | $40 | $75 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
181 | $5 | $18 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
174 | $29 | $100 |
| Beta 2 glycoprotein 1 antibody (autoantibody) measurement | 174 | $25 | $55 |
| Cardiolipin antibody (tissue antibody) measurement | 174 | $25 | $70 |
| Albumin level test A blood test that measures the amount of albumin, a protein made by the liver, in your body. |
173 | $5 | $17 |
| Blood potassium level test A blood test that measures the amount of potassium in your body. Potassium is an electrolyte that helps control heart and muscle function. |
168 | $5 | $16 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
161 | $5 | $18 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
135 | $5 | $44 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
126 | $37 | $120 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
123 | $36 | $158 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
121 | $36 | $200 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
115 | $58 | $200 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
111 | $52 | $208 |
| Liver enzyme (SGPT) level test A blood test that measures the level of the liver enzyme SGPT to assess liver function. |
110 | $5 | $18 |
| Liver enzyme (SGOT) level test A blood test that measures the level of the liver enzyme SGOT to help assess liver health. |
106 | $5 | $18 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
93 | $45 | $135 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
90 | $20 | $80 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
85 | $6 | $204 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
82 | $83 | $218 |
| Alkaline phosphatase level test A blood test that measures the level of alkaline phosphatase, an enzyme found in the liver and bones. |
76 | $5 | $18 |
| Blood sodium level test A laboratory test that measures the amount of sodium in your blood. Sodium is an electrolyte that helps regulate fluid balance and nerve function. |
73 | $5 | $16 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
73 | $122 | $200 |
| Immunoassay substance measurement A laboratory test that uses immunoassay techniques to measure the level of a specific substance in a sample. |
72 | $17 | $36 |
| Rheumatoid factor level | 71 | $5 | $15 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
69 | $12 | $44 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
63 | $13 | $55 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
62 | $13 | $44 |
| Measurement of dna antibody, single stranded | 62 | $12 | $46 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
55 | $24 | $60 |
| Wrist X-ray, 2 views An X-ray imaging test of the wrist using two different angles to visualize the bones and joints. |
52 | $26 | $55 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
46 | $40 | $290 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $42 | $70 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
44 | $11 | $45 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
43 | $25 | $70 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
38 | $25 | $75 |
| Suprascapular nerve injection An injection of anesthetic and/or steroid medication into the suprascapular nerve in the shoulder area. |
34 | $79 | $341 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
29 | $30 | $70 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
26 | $21 | $50 |
| X-ray of middle spine, 2 views An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints. |
24 | $25 | $70 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
23 | $29 | $146 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $124 | $195 |
| X-ray of foot, 2 views An X-ray imaging test of the foot using two different angles to create pictures of the bones and joints. |
20 | $21 | $60 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
17 | $25 | $60 |
| New patient office visit, complex (60-74 min) | 17 | $139 | $250 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
16 | $42 | $194 |
| X-ray of spine, 1 view A single-view X-ray image of the spine to visualize the bones and alignment. |
14 | $19 | $50 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
13 | $38 | $100 |
| Ultrasound-guided joint aspiration or injection Removal of fluid from or injection into a medium-sized joint using ultrasound guidance to ensure accurate placement. |
11 | $69 | $185 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.8% high complexity
91.3% medium
2.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,588
Total received (2018-2024)
Avg $1,370/year across 7 years
Top 17% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
576
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,568 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,565
2023
$1,219
2022
$441
2021
$255
2020
$631
2019
$2,699
2018
$2,778
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$409
Amgen Inc.
$286
ABBVIE INC.
$225
GlaxoSmithKline, LLC.
$154
UCB, Inc.
$120
Novartis Pharmaceuticals Corporation
$86
GENZYME CORPORATION
$82
Kyowa Kirin, Inc.
$52
E.R. Squibb & Sons, L.L.C.
$38
Lilly USA, LLC
$34
Radius Health, Inc.
$23
Sandoz Inc.
$21
Kiniksa Pharmaceuticals International, plc
$18
Genentech USA, Inc.
$18
Top 3 companies account for 58.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,094
Genentech USA, Inc.
$821
AstraZeneca Pharmaceuticals LP
$810
PFIZER INC.
$804
Novartis Pharmaceuticals Corporation
$735
E.R. Squibb & Sons, L.L.C.
$670
Janssen Biotech, Inc.
$575
UCB, Inc.
$490
AbbVie, Inc.
$469
GlaxoSmithKline, LLC.
$423
GENZYME CORPORATION
$343
ABBVIE INC.
$246
AbbVie Inc.
$227
Lilly USA, LLC
$210
Radius Health, Inc.
$200
Celgene Corporation
$167
Johnson & Johnson Health Care Systems Inc.
$136
MEDEXUS PHARMA, INC.
$136
Alexion Pharmaceuticals, Inc.
$135
Horizon Therapeutics plc
$133
Actelion Pharmaceuticals US, Inc.
$115
Ferring Pharmaceuticals Inc.
$94
Sobi, Inc
$89
MEDAC PHARMA, INC.
$77
DePuy Synthes Sales Inc.
$77
Kyowa Kirin, Inc.
$52
Takeda Pharmaceuticals U.S.A., Inc.
$43
Flexion Therapeutics, Inc.
$39
Mallinckrodt Hospital Products Inc.
$35
Horizon Pharma plc
$25
Ironwood Pharmaceuticals, Inc
$25
Sandoz Inc.
$21
Supernus Pharmaceuticals, Inc.
$20
Aurinia Pharma U.S., Inc.
$20
Kiniksa Pharmaceuticals International, plc
$18
Vertical Pharmaceuticals, LLC
$15
Top 3 companies account for 28.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · BEXSERO · Bimzelx · COSENTYX · Cimzia · Crysvita · DUZALLO · EUFLEXXA · EVENITY · Enbrel · FORTEO · HUMIRA · HYRIMOZ · Humira · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LORZONE · LUMIZYME · LUPKYNIS · LYRICA · MONOVISC · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · ORTHOVISC · Otezla · POMPE - DISEASE · PREVNAR - 13 · Prolia · RAYOS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMPONI ARIA · SKYRIZI · STELARA · Skyrizi · Strensiq · TALTZ · TAVNEOS · TREMFYA · TROKENDI XR · Tymlos · Uloric · VENTAVIS ILOPROST · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
76
Per 100K population
17.7
County median income
$77,684
Nearest hospital
SURGICAL INSTITUTE OF READING
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Borofsky is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with low-engagement industry engagement in the top 17% of PA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Borofsky experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Borofsky performed 115,026 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Borofsky receive payments from pharmaceutical companies?
Yes. Dr. Borofsky received a total of $9,588 from 36 companies across 576 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Borofsky's costs compare to other opticians in Wyomissing?
Dr. Borofsky's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Borofsky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Wyomissing
Browse opticians in Wyomissing ranked by procedure volume and transparency data.
Highest volume
Top Opticians in PA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in PA
Which PA opticians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology